TGFB2 and ovarian carcinoma: As shown in Table 1, increased TGF-β2 mRNA expression was related to a favorable OS but not associated with PFS in women with stage I and II ovarian cancer, while upregulated TGF-β2 mRNA levels were related to poor OS and PFS in women with stage III and IV ovarian carcinoma.